COVID truthers use four enticing promises to gain a loyal following.
Academic rigor, journalistic flair
Articles on Vaccines
Displaying 1 - 20 of 745 articles
New analysis answers questions about the ongoing effectiveness of COVID vaccines: How well they protect against infection, hospitalization and death months after initial doses or after a booster shot.
While mRNA vaccines are designed to last longer in the body than mRNA molecules typically would, they are also tested to ensure they are eliminated from livestock long before milking or slaughter.
Three factors that can speed up adoption of clinical research discoveries are context, tailoring resources and efficient knowledge sharing.
The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
The first vaccine against respiratory syncytial virus is 83% effective.
Polio vaccines have been a massive public health victory in the US. But purely celebratory messaging overlooks the ongoing threat if vaccination rates fall.
Oropharyngeal cancer has now become more common than cervical cancer in the US and the UK.
Africa has come a long way, in the post-COVID era, in boosting the morale around local production investments among local and foreign companies. But more is needed.
Similar to the patterns seen with COVID-19, flu and RSV, HMPV is making a comeback after years of being repressed by people wearing masks and social distancing.
Countries must ensure adequate and full immunisation of every child to curb polio mutations.
Avian influenza — commonly known as ‘bird flu’ — is infecting domestic and wild birds in Canada and around the world.
In reality, fungal infections cause thousands of deaths each year – making the need for vaccines urgent.
Avian influenza viruses have evolved to infect birds, but the current H5N1 outbreak is also infecting a wide range of mammals. This suggests that it could mutate into forms that threaten humans.
Catch-up vaccinations are free. These hints and tips will help you get started.
Cancer vaccines are an emerging personalised treatment for cancer. Using the same mRNA technology as COVID vaccines, they stimulate the immune system to destroy cancer cells.
Here’s why it’s taken so long to develop a vaccine for respiratory syncytial virus and what we can expect next.
You’d be surprised how far back the roots of anti-vaccine arguments stretch.
Middle age means staying a step ahead on both the medical and financial fronts.
Vaccination is often combined with an injection. It can also take the form of a nasal spray: an approach that is still rare, but which could be effective against Covid. Here’s why.
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Virologist, Queen's University Belfast
-
Associate Professor of Biology, Rochester Institute of Technology
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Microbiology, School of Medicine, University of Washington
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Assistant Professor of Political Science, Oklahoma State University
-
Senior Lecturer; MD, Victoria University
-
Professor of Immunology, RMIT University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
